Century Therapeutics (IPSC) Retained Earnings (2020 - 2026)
Century Therapeutics' (IPSC) quarterly Retained Earnings came in at -$813.6 million in Q1 2026, down 15.27% year-on-year from -$960.2 million in Q1 2025, and down 2.73% on a QoQ basis from -$791.9 million in Q4 2025.
Century Therapeutics (IPSC) Retained Earnings (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Retained Earnings data on file, last reported at -$813.6 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 15.27% year-over-year to -$813.6 million in Q1 2026; TTM through Mar 2026 was -$813.6 million, a 15.27% decrease from a year earlier, with the FY2025 full-year figure at -$791.9 million, down 1.22% from the prior year.
- Retained Earnings for Q1 2026 stood at -$813.6 million, down from -$791.9 million in the prior quarter.
- Over the last five years, Retained Earnings for IPSC reached as high as $758000.0 in Q3 2024 and fell as low as -$813.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$474.8 million across 5 years, with a median of -$550.4 million in 2023.
- Across the five-year window, Retained Earnings slumped 15222133.33% in 2022 and surged 126.86% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$519.1 million in 2022, then declined by 26.33% to -$655.8 million in 2023, then slipped by 19.3% to -$782.3 million in 2024, then retreated by 1.22% to -$791.9 million in 2025, then decreased by 2.73% to -$813.6 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$813.6 million in Q1 2026, -$791.9 million in Q4 2025, and $64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -622,000.00 |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | -813.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -813.56 Mn |
| Dec 31, 2025 | -791.92 Mn |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | -705.78 Mn |
| Dec 31, 2024 | -782.34 Mn |
| Sep 30, 2024 | 758,000.00 |
| Jun 30, 2024 | -309,000.00 |
| Mar 31, 2024 | -683.83 Mn |
| Dec 31, 2023 | -655.77 Mn |
| Sep 30, 2023 | -616.37 Mn |
| Jun 30, 2023 | -583.65 Mn |
| Mar 31, 2023 | -550.36 Mn |
| Dec 31, 2022 | -519.10 Mn |
| Sep 30, 2022 | -487.42 Mn |
| Jun 30, 2022 | -456.67 Mn |
| Mar 31, 2022 | -425.68 Mn |
| Dec 31, 2021 | -650,000.00 |
| Sep 30, 2021 | -63,000.00 |
| Jun 30, 2021 | -3,000.00 |